Marios Papadakis

5.0k total citations · 1 hit paper
259 papers, 2.8k citations indexed

About

Marios Papadakis is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Marios Papadakis has authored 259 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 46 papers in Molecular Biology and 43 papers in Physiology. Recurrent topics in Marios Papadakis's work include Alzheimer's disease research and treatments (27 papers), Parkinson's Disease Mechanisms and Treatments (15 papers) and MicroRNA in disease regulation (11 papers). Marios Papadakis is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Parkinson's Disease Mechanisms and Treatments (15 papers) and MicroRNA in disease regulation (11 papers). Marios Papadakis collaborates with scholars based in Germany, Egypt and Saudi Arabia. Marios Papadakis's co-authors include Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, Hubert Zirngibl, Peter C. Ambe, Maliheh Entezari, Mehrdad Hashemi and Shing Cheng Tan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Brain Research.

In The Last Decade

Marios Papadakis

233 papers receiving 2.7k citations

Hit Papers

Emerging role of exosomes in cancer progression and tumor... 2022 2026 2023 2024 2022 100 200 300

Peers

Marios Papadakis
Li Gao China
Marios Papadakis
Citations per year, relative to Marios Papadakis Marios Papadakis (= 1×) peers Li Gao

Countries citing papers authored by Marios Papadakis

Since Specialization
Citations

This map shows the geographic impact of Marios Papadakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios Papadakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios Papadakis more than expected).

Fields of papers citing papers by Marios Papadakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marios Papadakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios Papadakis. The network helps show where Marios Papadakis may publish in the future.

Co-authorship network of co-authors of Marios Papadakis

This figure shows the co-authorship network connecting the top 25 collaborators of Marios Papadakis. A scholar is included among the top collaborators of Marios Papadakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marios Papadakis. Marios Papadakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malik, Abdul, Malik Hassan Mehmood, Ambreen Malik Uttra, et al.. (2025). Eucalyptol attenuates indomethacin-induced gastric ulcers in rats by modulating the ICAM-1, eNOS and COX/LOX pathways: Insights from in silico, in vitro and in vivo approaches. Food and Chemical Toxicology. 199. 115319–115319.
2.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Mubarak Alruwaili, et al.. (2025). The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts. Neuroscience. 568. 202–208. 7 indexed citations
3.
Singh, Abhishek, Vishnu D. Rajput, Tatiana Minkina, et al.. (2025). Biogenic nanoparticles for managing salinity stress-related crop and environmental risks: realistic applications and challenges. Discover Sustainability. 6(1). 3 indexed citations
4.
Alsfouk, Bshra A., Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.. (2025). The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective. Brain Research Bulletin. 221. 111189–111189. 1 indexed citations
5.
Sharma, Aishwarya, Vishnu D. Rajput, Tatiana Minkina, et al.. (2024). In-depth exploration of nanoparticles for enhanced nutrient use efficiency and abiotic stresses management: Present insights and future horizons. Plant Stress. 14. 100576–100576. 48 indexed citations
6.
Al‐Gareeb, Ali I., Αθανάσιος Αλεξίου, Marios Papadakis, et al.. (2024). Role of Autophagy in Type 2 Diabetes Mellitus: The Metabolic Clash. Journal of Cellular and Molecular Medicine. 28(23). e70240–e70240. 2 indexed citations
7.
Khan, Azmat Ali, et al.. (2024). Investigation of in-vitro hypoglycaemic activity of the different fractions of black pepper (Piper nigrum). Results in Chemistry. 11. 101780–101780. 2 indexed citations
8.
Fatima, Ghizal, Gaber El‐Saber Batiha, Αθανάσιος Αλεξίου, et al.. (2024). Micronutrient interactions: Magnesium and its synergies in maternal–fetal health. Food Science & Nutrition. 12(10). 6913–6928. 6 indexed citations
9.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Sabrean Farhan Jawad, et al.. (2024). The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis. Journal of Inflammation. 21(1). 19–19. 4 indexed citations
10.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.. (2024). Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue. Molecular Neurobiology. 61(9). 7092–7108. 18 indexed citations
11.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου, et al.. (2024). Atheroprotective role of vinpocetine: an old drug with new indication. Inflammopharmacology. 32(6). 3669–3678. 3 indexed citations
12.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.. (2023). Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era. Immunity Inflammation and Disease. 11(4). e838–e838. 10 indexed citations
13.
Mahmoud, Mohamed H., Rehab Ahmed Rifaai, Michael Atef Fawzy, et al.. (2023). Diacerein modulates TLR4/ NF‐κB/IL‐1β and TRPC1/CHOP signalling pathways in gentamicin‐induced parotid toxicity in rats. Journal of Cellular and Molecular Medicine. 27(12). 1735–1744. 4 indexed citations
14.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.. (2023). Antidepressants and type 2 diabetes: highways to knowns and unknowns. Diabetology & Metabolic Syndrome. 15(1). 179–179. 15 indexed citations
15.
Ali, Naif H., Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.. (2023). Role of brain renin–angiotensin system in depression: A new perspective. CNS Neuroscience & Therapeutics. 30(4). e14525–e14525. 27 indexed citations
16.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου, et al.. (2023). Does vitamin D protect or treat Parkinson’s disease? A narrative review. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(1). 33–40. 20 indexed citations
17.
Alrouji, Mohammed, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.. (2023). The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases. Diabetology & Metabolic Syndrome. 15(1). 101–101. 47 indexed citations
18.
Dhar, Rajib, Sukhamoy Gorai, Arikketh Devi, et al.. (2023). Exosome: A megastar of future cancer personalized and precision medicine. SHILAP Revista de lepidopterología. 3(3). 26 indexed citations
19.
Dhar, Rajib, Sukhamoy Gorai, Sagnik Nag, et al.. (2023). Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance. Biomarkers. 28(6). 502–518. 18 indexed citations
20.
Spernovasilis, Nikolaos, et al.. (2021). Epidemics and pandemics: Is human overpopulation the elephant in the room?. Ethics Medicine and Public Health. 19. 100728–100728. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026